Non-small cell lung cancer patients who have progressed on a cetuximab-containing regimen may respond to erlotinib, Fox Chase Cancer Center researchers reported today at the annual meeting of the International Association for the Study of Lung Cancer.
Read more ...
The tablet PC could be Apple's next big thing
15 years ago
0 comments:
Post a Comment